Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen
STOCKHOLM, May 22, 2019 /PRNewswire/ — This statement is made by the Board of Directors[1] of Nuevolution AB (publ) (the “Company” or “Nuevolution”) pursuant to Rule II.19 of the Nasdaq Stockholm Takeover Rules (the “Takeover Rules”). Comment from Stig Løkke Pedersen, Chairman of the…
View more at https://www.prnewswire.com:443/news-releases/statement-by-the-board-of-directors-of-nuevolution-in-relation-to-the-public-offer-from-amgen-300854857.html
Comments Off on Statement by the Board of Directors of Nuevolution in Relation to the Public Offer From Amgen